The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke
Open accessAbstract
Background— Fetuin-A, a protein almost exclusively secreted by the liver, induces insulin resistance and subclinical inflammation in rodents. Circulating fetuin-A levels are elevated in humans with metabolic syndrome and insulin resistance, conditions that are associated with increased risk of cardiovascular disease. Methods and Results— We investigated the association between fetuin-A levels and the risk of future myocardial infarction (MI) and ischemic stroke (IS) in a case-cohort study based on the European Prospective Investigation into Cancer and Nutrition (EPIC)–Potsdam Study comprising 27 548 middle-aged subjects of the general population. Fetuin-A levels were measured in plasma of 227 individuals who developed MI, in 168 who developed IS, and in 2198 individuals who remained free of cardiovascular events during a mean follow-up of 8.2±2.2 years. Individuals in the highest compared with the lowest quintile of plasma fetuin-A had significantly increased risks of MI (relative risk, 3.80; 95% confidence interval, 2.37 to 6.10; P for trend <0.0001) and IS (relative risk, 3.93; 95% confidence interval, 2.17 to 7.12; P for trend <0.0001) after adjustment for sex and age. Additional adjustment for smoking status, body mass index, waist circumference, alcohol consumption, educational attainment, physical activity, hypertension, diabetes mellitus, total and high-density lipoprotein cholesterol, and C-reactive protein only moderately attenuated these risks (MI: relative risk, 3.25; 95% confidence interval, 2.01 to 5.28; P for trend <0.0001; IS: relative risk, 3.78; 95% confidence interval, 2.06 to 6.94; P for trend <0.0001). Conclusions— Our data provide evidence for a link between high plasma fetuin-A levels and an increased risk of MI and IS. Therefore, more research is warranted to determine the role of fetuin-A in the pathophysiology of cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Applied Survival Analysis: Regression Modeling of Time-to-Event Data
Hosmer, D. W., Lemeshow, S. A., & May, S. J. (2008) · Cited by 3,030
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.032 · Cited by 1,888
A case-cohort design for epidemiologic cohort studies and disease prevention trials
PRENTICE, R. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.1 · Cited by 1,439
Applying Cox Regression to Competing Risks
Lunn, M., & McNeil, D. (1995) · Biometrics · doi:10.2307/2532940 · Cited by 975
Barr, E. L. M., Zimmet, P. Z., Welborn, T. A., Jolley, D., Magliano, D. J., Dunstan, D. W., Cameron, A. J., Dwyer, T., Taylor, H. R., Tonkin, A. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685628 · Cited by 719
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
Targher, G., & Arcaro, G. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.021 · Cited by 551
Stefan, N., Hennige, A. M., Staiger, H., Machann, J., Schick, F., Kröber, S. M., Machicao, F., Fritsche, A., & Häring, H.-U. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1938 · Cited by 474
Self-citationPlasma fetuin-A levels and the risk of type 2 diabetes
Stefan, N., Fritsche, A., Weikert, C., Boeing, H., Joost, H.-G., Häring, H.-U., & Schulze, M. B. (2008) · Diabetes · doi:10.2337/db08-0538 · Cited by 379
Self-citationImproved Insulin Sensitivity and Resistance to Weight Gain in Mice Null for the Ahsg Gene
Mathews, S. T., Singh, G. P., Ranalletta, M., Cintron, V. J., Qiang, X., Goustin, A. S., Jen, K.-L. C., Charron, M. J., Jahnen-Dechent, W., & Grunberger, G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2450 · Cited by 342
Non-alcoholic fatty liver disease and the metabolic syndrome: An update
Rector, R. S., Thyfault, J. P., Wei, Y., & Ibdah, J. A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.185 · Cited by 332
Auberger, P., Falquerho, L., Contreres, J. O., Pages, G., Cam, G. L., Rossi, B., & Cam, A. L. (1989) · Cell · doi:10.1016/0092-8674(89)90098-6 · Cited by 321
Association Between Human Fetuin-A and the Metabolic Syndrome: Data From the Heart and Soul Study
Ix, J. H., Shlipak, M. G., Brandenburg, V. M., Ali, S., Ketteler, M., & Whooley, M. A. (2006) · Circulation · doi:10.1161/circulationaha.105.588723 · Cited by 316
Recruitment Procedures of EPIC-Germany
Boeing, H., Korfmann, A., & Bergmann, M. M. (1999) · Annals of Nutrition and Metabolism · doi:10.1159/000012787 · Cited by 302
Self-citationDENECKE, B., GRÄBER, S., SCHÄFER, C., HEISS, A., WÖLTJE, M., & JAHNEN-DECHENT, W. (2003) · Biochemical Journal · doi:10.1042/bj20030676 · Cited by 288
Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
Hennige, A. M., Staiger, H., Wicke, C., Machicao, F., Fritsche, A., Häring, H.-U., & Stefan, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001765 · Cited by 282
Self-citationFetuin-A and Incident Diabetes Mellitus in Older Persons
Ix, J. H. (2008) · JAMA · doi:10.1001/jama.300.2.182 · Cited by 267
Hepatic steatosis is associated with an increased risk of carotid atherosclerosis
Völzke, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1848 · Cited by 248
Tzoulaki, I., Murray, G. D., Lee, A. J., Rumley, A., Lowe, G. D. O., & Fowkes, F. G. R. (2007) · Circulation · doi:10.1161/circulationaha.106.635029 · Cited by 237
Szweras, M., Liu, D., Partridge, E. A., Pawling, J., Sukhu, B., Clokie, C., Jahnen-Dechent, W., Tenenbaum, H. C., Swallow, C. J., Grynpas, M. D., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112234200 · Cited by 214
Association of Serum Fetuin-A With Insulin Resistance in Type 2 Diabetic and Nondiabetic Subjects
Mori, K., Emoto, M., Yokoyama, H., Araki, T., Teramura, M., Koyama, H., Shoji, T., Inaba, M., & Nishizawa, Y. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1484 · Cited by 213
Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men
Targher, G., Bertolini, L., Padovani, R., Zenari, L., Zoppini, G., & Falezza, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2498 · Cited by 197
Ix, J. H., Chertow, G. M., Shlipak, M. G., Brandenburg, V. M., Ketteler, M., & Whooley, M. A. (2007) · Circulation · doi:10.1161/circulationaha.106.682450 · Cited by 160
Mehrotra, R., Westenfeld, R., Christenson, P., Budoff, M. J., Ipp, E., Takasu, J., Gupta, A., Norris, K. C., Ketteler, M., & Adler, S. G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00172.x · Cited by 154
Follow-Up Procedures in EPIC-Germany – Data Quality Aspects
Bergmann, M. M., Bussas, U., & Boeing, H. (1999) · Annals of Nutrition and Metabolism · doi:10.1159/000012789 · Cited by 140
Self-citationThe nucleotide and partial amino acid sequences of rat fetuin
Rauth, G., Poeschke, O., Fink, E., Eulitz, M., Tippmer, S., Kellerer, M., Häring, H.-U., Nawratil, P., Haasemann, M., Jahnen‐Dechent, W., et al. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb16663.x · Cited by 134
Design Options for Molecular Epidemiology Research within Cohort Studies
Rundle, A. G., Vineis, P., & Ahsan, H. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0860 · Cited by 117
Design options in epidemiologic research. An update.
Miettinen, O. S. (1982) · PubMed · Cited by 111
Association between nonalcoholic fatty liver disease and coronary artery disease
Arslan, U., Türkoğlu, S., Balcıoğlu, S., Tavıl, Y., Karakan, T., & Çengel, A. (2007) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282583c0d · Cited by 110
Measures of Quality Control in the German Component of the EPIC Study
Kroke, A., Bergmann, M. M., Lotze, G., Jeckel, A., Klipstein‐Grobusch, K., & Boeing, H. (1999) · Annals of Nutrition and Metabolism · doi:10.1159/000012788 · Cited by 76
Self-citationSystemic and local levels of fetuin-A in calcific aortic valve stenosis
Kaden, J. J., Reinöhl, J., Blesch, B., Brueckmann, M., Haghi, D., Borggrefe, M. M., Schmitz, F., Klomfaß, S., Pillich, M., & Ortlepp, J. R. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.2.193 · Cited by 49
Joint effects of risk factors for stroke and transient ischemic attack in a German population
Weikert, C., Berger, K., Heidemann, C., Bergmann, M. M., Hoffmann, K., Klipstein‐Grobusch, K., & Boeing, H. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0358-x · Cited by 43
Self-citationEmerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease
Mehrotra, R. (2007) · Kidney International · doi:10.1038/sj.ki.5002355 · Cited by 43
Fetuin-A is not associated with mortality in chronic kidney disease
Ix, J. H., Shlipak, M. G., Sarnak, M. J., Beck, G. J., Greene, T., Wang, X., Kusek, J. W., Collins, A. J., Levey, A. S., & Menon, V. (2007) · Kidney International · doi:10.1038/sj.ki.5002549 · Cited by 35
Cited by
Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988
Self-citationGaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R., Bugianesi, E., & Gastaldelli, A. (2013) · Nutrients · doi:10.3390/nu5051544 · Cited by 822
Schwenzer, N. F., Springer, F., Schraml, C., Stefan, N., Machann, J., & Schick, F. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.023 · Cited by 749
Self-citationFrancque, S. M., van der Graaff, D., & Kwanten, W. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.005 · Cited by 556
The role of hepatokines in metabolism
Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500
Metadata
- Authors
- Weikert, C., Stefan, N., Schulze, M. B., Pischon, T., Berger, K., Joost, H.-G., Häring, H.-U., Boeing, H., & Fritsche, A.
- Venue
- Circulation
- Published
- 2008-12-09
- Volume
- 118
- Issue
- 24
- Pages
- 2555-2562
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1969316714
- Cited by
- 310
- References
- 37
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.